Predicting neuroblastoma outcomes with molecular evolution

Predicting neuroblastoma outcomes with molecular evolution

A research team led by the German Cancer Research Center in Heidelberg, Germany, has discovered that...
read more
Diminishing health benefits of living in cities for children and teens

Diminishing health benefits of living in cities for children and teens

The advantages of living in cities for children an...
read more
Research team confirms the long-term safety of methylphenidate in children and adolescents with ADHD

Research team confirms the long-term safety of methylphenidate in children and adolescents with ADHD

An international research team led by Professor Ia...
read more
Over-the-counter birth control option will be considered in May by FDA advisers

Over-the-counter birth control option will be considered in May by FDA advisers

Illustration: Annelise Capossela/Axios Food and Dr...
read more
Using bacteria to target cancer treatment

Using bacteria to target cancer treatment

When an outlet isn’t designed for your plug,...
read more
Novel actigraphy device can provide objective assessment of sleep and fatigue risk in emergency medicine physicians

Novel actigraphy device can provide objective assessment of sleep and fatigue risk in emergency medicine physicians

ReadiScores—fatigue data gathered from a novel a...
read more
Researchers propose a novel biomarker for early diagnosis of Alzheimers disease

Researchers propose a novel biomarker for early diagnosis of Alzheimers disease

Alzheimer’s disease is the most prominent ca...
read more
SBRT: Alternative to Surgery in Early Stage Lung Cancer?

SBRT: Alternative to Surgery in Early Stage Lung Cancer?

Stereotactic body radiation therapy (SBRT) and sur...
read more
AWS announces healthcare workforce accelerator cohort

AWS announces healthcare workforce accelerator cohort

The companies selected for the newest AWS Healthca...
read more
Amgen-Sanofi Patent Case Divides Makers of Antibody Drugs

Amgen-Sanofi Patent Case Divides Makers of Antibody Drugs

(Reuters) – Amgen Inc’s battle with Sa...
read more